MediMix Oncology
  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
Browse Tag

poster

159 Articles

DESTINY-Pan Tumor 02 Subgroup Analysis

17 July 2024

GEICAM/2014-12 FLIPPER TRIAL

17 July 2024

DIFFERENTIAL GENOMIC PROFILING of PR neg and ER low subtypes

16 July 2024

CYCLIN E1 AMPLIFICATION IN ADVANCED BC

16 July 2024

AIPAC 003

16 July 2024

An ITC of first-line dual immunotherapy options in advanced melanoma

3 July 2024

The RegoMel trial

2 July 2024

LEAP-004 study: > 4 year follow up

20 June 2024

5-year outcomes of CheckMate 9LA study

15 June 2024
ELCC 2024Lung Cancer

PULSE, a non-inferiority study of maintenance Pembro at Usual or Low doSE

4 April 2024

Dr Jordi Remon Masip, medical oncologist at Institut Gustave Roussy, Villejuif,...

« Previous 1 … 5 6 7 8 9 … 16 Next »

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok